- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Jazz Pharmaceuticals Plc
Add to PortfolioJAZZ:US
45.8600 USD 0.9400 2.09%As of 20:10:00 ET on 05/25/2012.
Snapshot for Jazz Pharmaceuticals Plc (JAZZ)
| Open: | 44.7500 | Day's Range: | 44.2422 - 46.1500 | Volume: | 924,028 | Bid: | 45.8600 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 44.9200 | 52wk Range: | 26.4300 - 54.5000 | 1-Yr Rtn: | +62.57% | Ask: | 45.8700 |
Key Statistics for JAZZ
| Current P/E Ratio (ttm) | 14.8896 |
|---|---|
| Estimated P/E (12/2012) | 10.1550 |
| Earnings Per Share (USD) (ttm) | 3.0800 |
| Est. EPS (USD) (12/2012) | 4.5160 |
| Est. PEG Ratio | 0.3125 |
| Market Cap (M USD) | 2,601.77 |
| Shares Outstanding (M) | 56.73 |
| Enterprise Value (M USD) (ttm) | 2,357.55 |
| Enterprise Value/EBITDA (ttm) | 14.92 |
| Price/Book (mrq) | 3.3278 |
| Price/Sale (ttm) | 6.2882 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/27/2012 |
More JAZZ Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for JAZZ
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for JAZZ
Jazz Pharmaceuticals Plc. is a specialty biopharmaceutical company. The Company is focused on identifying, developing and commercializing products that address unmet medical needs. Jazz Pharmaceutical has a diverse portfolio of products in the areas of narcolepsy, severe chronic pain, psychiatry and women's health.
| Bruce C CozaddChairman/CEO | Kathryn E Falberg "Kate"Senior VP/CFO |
| Janne L T WisselSenior VP/Chf Regulatory Ofcr | Russell J CoxSenior VP/Chf Commercial Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page